As the Eμ-TCL1 mouse model mimics CLL with unmutated immunoglobulins73, our data suggest treatment efficacy of anti-galectin-9 specifically for this more aggressive form of CLL. The gene discussed is LGALS9; the disease is B-cell chronic lymphocytic leukemia.